PCB ranked No. 8 in Pharmacology nationally
Zou Lab: Duke researchers find a new weakness in cancer cells: an 'in-between’ phase
PCB Retreat Showcases Research and Honors Trainees
Oliver Lab: Basal Stem Cells Identified as Origin of Small Cell Lung Cancer in Lab Models
- PCB ranked No. 8 in Pharmacology nationally
- Zou Lab: Duke researchers find a new weakness in cancer cells: an 'in-between’ phase
- PCB Retreat Showcases Research and Honors Trainees
- Oliver Lab: Basal Stem Cells Identified as Origin of Small Cell Lung Cancer in Lab Models
Duke Research Saves Lives
Duke’s relentless pursuit of scientific innovation transforms groundbreaking discoveries into life-changing patient care and healthier communities. Explore how Duke researchers are changing people’s lives across North Carolina and around the world.
PCB Research in the News
- McDonnell Lab patent highlighted as part of Duke's ranking in the National Academy of Inventors’ “2025 Top 100 Worldwide Universities Granted U.S. Utility Patents” list [02.12.26]
- Oliver Lab recognized for Nature publication on small-cell lung cancer (SCLC) research [01.07.26]
- Newgard Lab collaboration resulted in drug for severe form of liver disease [09.05.24]
Lab Spotlight: The Darnell Lab
The Darnell lab links cellular metabolism to gene expression by defining how amino acid limitation directly disrupts translation. This work provides insight into why some cancers respond to certain drugs.
Alumni Spotlight on Jing Yang: Persist Through Setbacks and Enjoy the Journey
PhD alumna Jing Yang, PhD, a professor of pharmacology and pediatrics at UC San Diego, said Duke’s supportive culture and strong emphasis on mentorship still guide her scientific approach and career.
Invest in Our Future
At Duke University School of Medicine, donors play a vital role in fostering innovation, enhancing patient care, and training the next generation of health care leaders. Your contributions not only sustain and elevate existing programs but also pave the way for groundbreaking discoveries.